Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F List

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
The Lancet. Haematology|January 15, 2018
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trialRami Komrokji, Guillermo Garcia-Manero, Lionel Ades, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.
Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Biomarker Research|August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG reportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2021
Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic SyndromesDavid A Sallman, Amy E DeZern, Guillermo Garcia-Manero, et al.
Blood|May 14, 2008
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDSLi Zhou, Aaron N Nguyen, Davendra Sohal, et al.
Cancer Discovery|April 5, 2019
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in HematopoiesisJong Jin Jeong, Xiaorong Gu, Ji Nie, et al.
Blood Advances|November 19, 2019
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysisKathy L McGraw, Chia-Ho Cheng, Y Ann Chen, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
The Lancet. Haematology|January 15, 2018
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trialRami Komrokji, Guillermo Garcia-Manero, Lionel Ades, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.
Blood|August 9, 2013
STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patientsAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
Biomarker Research|August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG reportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2021
Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic SyndromesDavid A Sallman, Amy E DeZern, Guillermo Garcia-Manero, et al.
Blood|May 14, 2008
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDSLi Zhou, Aaron N Nguyen, Davendra Sohal, et al.
Cancer Discovery|April 5, 2019
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in HematopoiesisJong Jin Jeong, Xiaorong Gu, Ji Nie, et al.
Blood Advances|November 19, 2019
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysisKathy L McGraw, Chia-Ho Cheng, Y Ann Chen, et al.
Pageof 22